Phase 2 evaluation of the nilotinib-paclitaxel combination in patients with rare solid tumors: Rapid analysis and response evaluation of combination anti-neoplastic agents in rare tumors trial 1 (RARE CANCER 1).

Authors: Sarah Shin, Andre DeSouza, Jared C. Foster, Naoko Takebe, Geraldine Helen O'Sullivan Coyne, Sarah Miller, Brooke Augustine, Mary Jane Ong, Lamin Juwara, Jessica Mukherjee, Ning Ma, James H. Doroshow, Alice P. Chen

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.3015

Source: Full article

---

Abstract

3015